Steve Chaplin

1.3k total citations
230 papers, 804 citations indexed

About

Steve Chaplin is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Steve Chaplin has authored 230 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 22 papers in Surgery and 19 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Steve Chaplin's work include Diabetes Treatment and Management (17 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Pharmacology and Obesity Treatment (10 papers). Steve Chaplin is often cited by papers focused on Diabetes Treatment and Management (17 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Pharmacology and Obesity Treatment (10 papers). Steve Chaplin collaborates with scholars based in United Kingdom, United States and Denmark. Steve Chaplin's co-authors include Kate Khair, Michael Holland, Simon Fletcher, Debra Pollard, D. Nicholas Bateman, S. T. Knuth, Sunil Bhandari, Felipe A. Castro, J Black and Camelia S. Sima and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Comparative Physiology B and Haemophilia.

In The Last Decade

Steve Chaplin

180 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Chaplin United Kingdom 11 143 122 105 83 77 230 804
Jamie N. Brown United States 19 92 0.6× 72 0.6× 28 0.3× 84 1.0× 70 0.9× 69 911
Gerardo Machnicki United States 15 188 1.3× 47 0.4× 39 0.4× 75 0.9× 65 0.8× 42 790
Steven C. Martin United Kingdom 17 75 0.5× 76 0.6× 78 0.7× 84 1.0× 42 0.5× 53 822
J Bryant United Kingdom 20 86 0.6× 267 2.2× 69 0.7× 106 1.3× 140 1.8× 32 1.4k
P.A. Laires Portugal 14 78 0.5× 27 0.2× 60 0.6× 126 1.5× 65 0.8× 77 1.4k
Michal Shani Israel 19 63 0.4× 91 0.7× 59 0.6× 191 2.3× 98 1.3× 89 1.2k
Keiko Honda Japan 19 56 0.4× 66 0.5× 49 0.5× 175 2.1× 158 2.1× 50 1.2k
Rebecca S. Finley United States 14 119 0.8× 92 0.8× 31 0.3× 98 1.2× 29 0.4× 34 943
Dolores Montero Spain 16 119 0.8× 125 1.0× 148 1.4× 75 0.9× 25 0.3× 35 1.3k
Albert Akpalu Ghana 17 229 1.6× 143 1.2× 15 0.1× 94 1.1× 71 0.9× 63 1.4k

Countries citing papers authored by Steve Chaplin

Since Specialization
Citations

This map shows the geographic impact of Steve Chaplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Chaplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Chaplin more than expected).

Fields of papers citing papers by Steve Chaplin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Chaplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Chaplin. The network helps show where Steve Chaplin may publish in the future.

Co-authorship network of co-authors of Steve Chaplin

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Chaplin. A scholar is included among the top collaborators of Steve Chaplin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Chaplin. Steve Chaplin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chaplin, Steve. (2023). Deucravacitinib for moderate to severe plaque psoriasis. Prescriber. 34(8-9). 31–33.
2.
Chaplin, Steve. (2023). Semaglutide for weight management in adults. Prescriber. 34(5). 29–31.
3.
Chaplin, Steve. (2023). Tezepelumab as add‐on treatment for severe asthma. Prescriber. 34(3). 13–14. 2 indexed citations
4.
Chaplin, Steve. (2023). NICE on the assessment and management of self‐harm. Prescriber. 34(1). 21–22.
5.
Chaplin, Steve. (2023). NICE on the diagnosis and management of osteoarthritis. Prescriber. 34(2). 15–16. 2 indexed citations
6.
Chaplin, Steve. (2023). Ryeqo for the treatment of the symptoms of uterine fibroids. Prescriber. 34(1). 31–32.
7.
Chaplin, Steve. (2023). Tirzepatide for the treatment of adults with type 2 diabetes. Prescriber. 34(7). 27–28. 1 indexed citations
8.
Chaplin, Steve, et al.. (2022). The lived experience of women with a bleeding disorder: A systematic review. Research and Practice in Thrombosis and Haemostasis. 6(1). e12652–e12652. 20 indexed citations
9.
Chaplin, Steve, et al.. (2021). Haemophilia specialist nurses’ perceptions of haemophilia B. SHILAP Revista de lepidopterología. 8(1). 119–127.
10.
Castro, Felipe A., et al.. (2020). Disease burden and remaining unmet need in patients with haemophilia A treated with primary prophylaxis. Haemophilia. 27(1). 113–119. 24 indexed citations
11.
Chaplin, Steve. (2019). Keeping a positive outlook: Margaret Monk. 6(1). s29–s32.
12.
Chaplin, Steve. (2019). ”Take your shots and take what comes”: Rex Jepson. 6(1). s1–s9.
13.
Pollard, Debra & Steve Chaplin. (2018). Subcutaneous injection: learning from experience in other specialties. 5(1). 35–41. 1 indexed citations
14.
Khair, Kate & Steve Chaplin. (2017). What is a nurse-led service? A discussion paper. 4(1). 4–13. 14 indexed citations
15.
Chaplin, Steve. (2016). The use of tranexamic acid in reducing bleeding complications. 3(2). 62–70. 5 indexed citations
16.
Khair, Kate & Steve Chaplin. (2016). The impact on parents of having a child with haemophilia. 3(2). 4–14. 4 indexed citations
17.
Chaplin, Steve & Giles Dunnill. (2015). Otezla for plaque psoriasis and psoriatic arthritis. Prescriber. 26(13-16). 33–35. 1 indexed citations
18.
Chaplin, Steve & Derek Connolly. (2009). Ranolazine: novel add‐on treatment for stable angina. Prescriber. 20(14). 29–32.
19.
Stalker, Kirsten, et al.. (2003). Care and treatment? supporting children with complex needs in healthcare settings. Strathprints: The University of Strathclyde institutional repository (University of Strathclyde). 6 indexed citations
20.
Bateman, D. Nicholas & Steve Chaplin. (1988). New Drugs: Adverse reactions. I. BMJ. 296(6624). 761–764. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jamie N. Brown Breakdown of academic impact, for papers by Gerardo Machnicki Breakdown of academic impact, for papers by Steven C. Martin Breakdown of academic impact, for papers by J Bryant Breakdown of academic impact, for papers by P.A. Laires Breakdown of academic impact, for papers by Michal Shani Breakdown of academic impact, for papers by Keiko Honda Breakdown of academic impact, for papers by Rebecca S. Finley Breakdown of academic impact, for papers by Dolores Montero Breakdown of academic impact, for papers by Albert Akpalu
Rankless by CCL
2026